Tag Archives: oncology

35th European Society for Medical Oncology Congress

Posted on 23 September 2010 by Ask-Cato.com Contributor

Image via Wikipedia The annual European Society for Medical Oncology (ESMO) meeting brings together medical oncologists from both Europe and all parts of the world.  As per ESMO’s 2010 meeting President, Dr. David Kerr, announcement: The ESMO Congress is a … Continue reading →

Posted in Conferences and Meetings | Tagged , , , , , , , | 1 Comment

Cato at the 12th World Congress on Gastrointestinal Cancer

Posted on 30 June 2010 by Evan Richardson

Cato Research will be attending the European Society for Medical Oncology‘s (ESMO)  12th World Congress on Gastrointestinal Cancer in Barcelona, Spain from 30 June to 03 July 2010.  ESMO is the leading European professional organization representing medical oncologists.  The conference … Continue reading →

Posted in Conferences and Meetings | Tagged , , , , , , | Comments Off

Optimizing Drug Development and Preclinical Considerations for Oncology Indications

Posted on 25 May 2010 by Evan Richardson

The Montgomery County (Maryland) Department of Economic Development will be hosting its next lunch meeting on Thursday, 27 May 2010 at the Shady Grove Innovation Center.  The topic of the meeting will be, “Optimizing Drug Development and Preclinical Considerations for … Continue reading →

Posted in Conferences and Meetings | Tagged , , , , , | 1 Comment

DDMAC Sends Warning Letter Over Unbranded Websites

Posted on 17 May 2010 by Leo DiNapoli

If you judge, investigate. – Seneca I know you just read the title, but let me say it again with some emphasis:  DDMAC Sends Warning Letter Over Unbranded Websites.  That’s right, a warning letter over websites that contained no “direct” … Continue reading →

Posted in FDA, Industry News | Tagged , , , , , , , , , , , , , | 2 Comments

Challenges associated with oncology development within an immunotherapeutic platform

Posted on 18 March 2010 by Ask-Cato.com Contributor

Although cancer immunotherapeutics (intended to treat already existing cancers by strengthening the body’s natural defenses) represent a very active area of development world wide, few cancer immunotherapeutics have been approved to date. Unfortunately, the overall clinical benefit in patients treated … Continue reading →

Posted in Clinical Trials | Tagged , , , , | Comments Off